Table 3 Transmural gradient of longitudinal strain (%) in healthy controls and HCM patients
Segments | TGLS in healthy controls | TGLS in HCM patients | ||
|---|---|---|---|---|
Mean ± SD | 95% CI | Mean ± SD | 95% CI | |
basAntSept | -1.97 ± 1.49 | -2.65 to -1.29 | 0.08 ± 2.20 | -0.68 to 0.81 |
basSept | -1.49±1.06 | -1.97 to -1.01 | 2.73 ± 2.65* | 1.89 to 3.59 |
basInf | -2.16±1.81 | -2.98 to -1.33 | -0.08 ± 3.93 | -1.39 to 1.26 |
basPost | -1.91 ± 1.42 | -2.56 to -1.27 | -2.61 ± 4.41 | -4.11 to -1.17 |
basLat | -2.82±2.03 | -3.74 to -1.89 | -3.90 ± 4.10 | -5.31 to -2.64 |
basAnt | -2.69±1.75 | -3.49 to -1.89 | -2.87 ± 2.65 | -3.77 to -2.05 |
midAntSept | -3.83±2.27 | -4.86 to -2.80 | -4.54 ± 3.23 | -5.69 to -3.43 |
midSept | -3.80±3.67 | -5.47 to -2.13 | 1.11 ± 2.58* | 0.22 to 1.93 |
midInf | -3.38±1.79 | -4.20 to -2.57 | 1.11 ± 3.42* | -0.06 to 2.34 |
midPost | -4.73±2.11 | -5.69 to -3.78 | -2.60 ± 3.83* | -4.10 to -1.33 |
midLat | -4.10±1.85 | -4.95 to -3.26 | -4.64 ± 3.74 | -5.84 to -3.45 |
midAnt | -3.30±2.10 | -4.25 to -2.34 | -4.17 ± 2.88* | -5.18 to -3.16 |
apAntSept | -9.82±3.69 | -11.49 to -8.14 | -12.22 ± 7.62 | -15.36 to -9.54 |
apSept | -10.19±2.08 | -11.14 to -9.24 | -10.82 ± 6.43 | -12.90 to -8.67 |
apInf | -10.49±3.41 | -12.09 to -8.90 | -11.06 ± 7.24 | -13.69 to -8.46 |
apPost | -9.93±2.87 | -11.23 to -8.62 | -9.41 ± 7.22 | -12.43 to -6.58 |
apLat | -9.96±3.60 | -11.60 to -8.32 | -10.82 ± 6.14 | -13.02 to -8.82 |
apAnt | -9.90±3.64 | -11.60 to -8.19 | -12.07 ± 6.84 | -14.57 to -9.84 |
Total | -5.33±4.20 | -5.76 to -4.91 | -4.61 ± 6.72 | -5.18 to -4.12 |